Keynote: Improving access and delivery of healthcare to affected communities affected by NTDs: strategies employed by MSF. | |||||
Tue20 Sep01:45pm(25 mins)
|
![]() |
Dr Margriet den Boer | |||
Track : Session 3
Room: Virtual meeting
|
Keynote: A qualitative study on visceral leishmaniasis (VL) patients and stakeholders regarding their perception about new drug formulations in North Bihar, India | |||||
Tue20 Sep02:10pm(25 mins)
|
![]() |
Dr Sweta Singh | |||
Track : Session 3
Room: Virtual meeting
|